Back to results
US 6,235,281 B1Granted
Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
AssigneeKnoll, Inc.
InventorsRoswitha Stenzel, Martin Kaul, Lothar Daum, Joachim Kempeni, Christa Raab, Sibylle Schaefer
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of TNF antagonists for producing drugs for the treatment of disorders characterized by elevated serum levels of interleukin-6.
Claims4
A method of treating a patient with septicemia wherein said patient has serum levels of interleukin-6 (IL-6) above 1.000 p/ml comprising:
- administering a therapeutically effective amount of a tumor necrosis factor (TNF) antagonist to said patient.
Dependencies are inferred from the claim text.